Reset filter
Trefwoorden
Psychiatres ×
Meer tonen Trefwoorden
Inhoudsopgave
  1. 1. Klinische studie
  2. 2. Routinedocumentatie
  3. 3. Register-/kohortstudies
  4. 4. Kwaliteitswaarborging
  5. 5. Datastandaard
  6. 6. Patiëntenvragenlijst
  7. 7. Medisch vakgebied
Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

816 Zoekresultaten.
Relevantie Beoordeling Nieuwe eerst Oude eerst

Eligibility Major Depressive Disorder NCT00479453

- 20-09-21 - 1 Formulier, 2 Itemgroepen, 11 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Lilly's Emotional and Physical Symptoms of Depression; ODM derived from: https://clinicaltrials.gov/show/NCT00479453

Admission checklist Psychiatry UKM - Admission checklist

- 20-09-21 - 1 Formulier, 3 Itemgroepen, 21 Data-elementen, 2 Talen
Itemgroepen: Patient demographics, Admission status, Documentation
Admission checklist converted to ODM format. Routine documentation of University Hospital of Münster. Publication granted by Univ.-Prof. Dr. med. Volker Arolt

Visit 2 - CRFs Paliperidone Palmitate Schizophrenia NCT01515423

- 20-09-21 - 1 Formulier, 28 Itemgroepen, 290 Data-elementen, 1 Taal
Itemgroepen: Date of visit, ECG, Vital signs, Pharmacokinetics, Blood Sample, Paliperidone, Lab Sample Central Lab, Urine Dipstick Pregnancy Test, Urine Drug Screen, Physical Examination, Abnormal Involuntary Movement Scale, Barnes Akathisia Rating Scale, Simpson Angus Rating Scale, Columbia - Suicide Severity Rating Scale (C-SSRS) Since Last Visit Version, Investigator Evaluation of lnjection site, Subject Evaluation of lnjection site, Positive and Negative Syndrome Scale for Schizophrenia, Clinical Global Impression - Severity, Personal and Social Performance Scale, Administration of trial medication, Medication Preference Questionnaire, Involvement Evaluation Questionnaire (Baseline), Resource Use Questionnaire A Hospitalisation, Resource Use Questionnaire B Emergency room visits without hospitalisation, Resource Use Questionnaire C Day clinic, Resource Use Questionnaire D Night clinic, Resource Use Questionnaire E Outpatient treatment, Resource Use Questionnaire F Daily living, Resource Use Questionnaire G Productivity of subject, Medication Kit Dispensation
A Randomized, Multicenter, Double-Blind, Non-inferiority Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Subjects With Schizophrenia Study Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT01515423 Sponsor: Janssen Research & Development, LLC Other drug name: TREVICTA®

Eligibility Schizophrenia NCT00369577

- 20-09-21 - 1 Formulier, 2 Itemgroepen, 19 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
StaccatoTM Loxapine for Inhalation in Schizophrenic Patients With Agitation.; ODM derived from: https://clinicaltrials.gov/show/NCT00369577

Visit 8 - CRFs Paliperidone Palmitate Schizophrenia NCT01515423

- 20-09-21 - 1 Formulier, 28 Itemgroepen, 277 Data-elementen, 1 Taal
Itemgroepen: Date of visit, Randomization, ECG, Vital signs, Pharmacokinetics, Blood Sample, Paliperidone, Lab Sample Central Lab, Urine Dipstick Pregnancy Test, Physical Examination, Abnormal Involuntary Movement Scale, Barnes Akathisia Rating Scale, Simpson Angus Rating Scale, Columbia - Suicide Severity Rating Scale (C-SSRS) Since Last Visit Version, Investigator Evaluation of lnjection site, Subject Evaluation of lnjection site, Positive and Negative Syndrome Scale for Schizophrenia, Clinical Global Impression - Severity, Personal and Social Performance Scale, Administration of trial medication, Medication Preference Questionnaire, Involvement Evaluation Questionnaire (Post-Baseline), Resource Use Questionnaire A Hospitalisation, Resource Use Questionnaire B Emergency room visits without hospitalisation, Resource Use Questionnaire C Day clinic, Resource Use Questionnaire D Night clinic, Resource Use Questionnaire E Outpatient treatment, Resource Use Questionnaire F Daily living, Resource Use Questionnaire G Productivity of subject, Medication Kit Dispensation
A Randomized, Multicenter, Double-Blind, Non-inferiority Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Subjects With Schizophrenia Study Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT01515423 Sponsor: Janssen Research & Development, LLC Other drug name: TREVICTA®

Koerpertherapie MS University Hospital Muenster (UKM)

- 20-09-21 - 1 Formulier, 8 Itemgroepen, 25 Data-elementen, 1 Taal
Itemgroepen: Patient Information, Preliminary Talk, Treatment Goals, Compliance, Benefit, Treatment Procedure, Therapy Unit, OPS
Hospital Routine Documentation Form at the University Hospital Muenster. Original Form name: KBT-Dokumentationsbogen.

Eligibility Perimenopausal Depression NCT00060736

- 20-09-21 - 1 Formulier, 2 Itemgroepen, 20 Data-elementen, 1 Taal
Itemgroepen: Criteria, Exclusion Criteria
The Effects of Estrogen Withdrawal on Mood Symptoms in Women; ODM derived from: https://clinicaltrials.gov/show/NCT00060736

Eligibility Schizophrenia NCT00686140

- 20-09-21 - 1 Formulier, 2 Itemgroepen, 12 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT00686140

Admission checklist Psychiatry UKM - Admission checklist

- 20-09-21 - 1 Formulier, 3 Itemgroepen, 21 Data-elementen, 2 Talen
Itemgroepen: Patient demographics, Admission status, Documentation
Admission checklist converted to ODM format. Routine documentation of University Hospital of Münster. Publication granted by Univ.-Prof. Dr. med. Volker Arolt.

Eligibility Depression NCT00076258

- 17-09-21 - 1 Formulier, 2 Itemgroepen, 19 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Adding Exercise to Antidepressant Medication Treatment for Depression; ODM derived from: https://clinicaltrials.gov/show/NCT00076258

Eligibility Depressive Disorder, Major NCT00223288

- 17-09-21 - 1 Formulier, 2 Itemgroepen, 12 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Impact of Caregiver Depression on Asthma in the Child; ODM derived from: https://clinicaltrials.gov/show/NCT00223288

Brain Dopamine D3 receptor occupancy, pharmacokinetics and safety of single oral doses of GSK618334, using 11C-PHNO as PET ligand NCT00814957 - Day -1 - 12-Lead ECG; Summary Holter; Summary Holter Abnormalities; Vital Signs; Electronically Transferred Lab Data; Urinalysis; PET; Functional MRI Scan; MRI Scan; Randomisation Number

- 17-09-21 - 1 Formulier, 12 Itemgroepen, 107 Data-elementen, 1 Taal
Itemgroepen: Date of Visit, 12-Lead ECG, Summary Holter, Summary Holter Abnormalities, Vital Signs - Pre-Baseline Scan, Electronically Transerred Lab Data , Urinalysis - Dipstick Details , Urinalysis - Microscopy Details , PET - Scan Baseline, Functional MRI Scan, MRI Scan, Randomisation Number
Study ID: 110269 Clinical Study ID: 110269 Study Title: An open label positron emission tomography study in healthy male subjects to investigate brain Dopamine D3 receptor occupancy, pharmacokinetics and safety of single oral doses of GSK618334, using 11C-PHNO as PET ligand Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00814957 Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: positron emission tomography, GSK618334 Study Indication: Substance Dependence

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial